ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IKA Ilika Plc

27.50
-0.50 (-1.79%)
Last Updated: 14:09:37
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ilika Plc LSE:IKA London Ordinary Share GB00B608Z994 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -1.79% 27.50 27.00 28.00 28.00 27.50 28.00 87,732 14:09:37
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 702k -7.3M -0.0459 -5.99 43.72M

Ilika plc Collaboration with Galvani Bioelectronics (3157Z)

14/03/2017 7:00am

UK Regulatory


Ilika (LSE:IKA)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Ilika Charts.

TIDMIKA

RNS Number : 3157Z

Ilika plc

14 March 2017

Ilika plc

("Ilika" or the "Company")

Ilika and Galvani Bioelectronics enter into collaboration in Bioelectronics Project

Ilika (AIM: IKA), a pioneer in materials innovation and solid-state battery technology, announces a two-year collaborative project with Galvani Bioelectronics to develop a solid state battery for miniature medical implants. Ilika's Stereax(TM) batteries have a high power density, a long battery life and they can be produced in miniature form, making them particularly suitable for these micro-devices.

This collaboration aims to deliver key components of bioelectronic devices, which have the potential to provide treatments for serious health conditions, through the body's own nervous system.

The GBP1.0 million development project is supported by funding of GBP0.7 million, which Ilika will receive from Innovate UK and the Medical Research Council.

Commenting on this grant award, Graeme Purdy, Ilika CEO, said: "This partnership with Galvani Bioelectronics, using Ilika's lithium-ion Stereax battery technology, may provide the potential to treat diseases that have so far been difficult to manage. Collaborations like this are critical to the delivery of advances in the field of solid state battery development."

For more information, contact:

 
 Ilika plc                                              www.ilika.com 
 Graeme Purdy, Chief                               Tel: 023 8011 1400 
  Executive 
 Steve Boydell, Finance 
  Director 
 
 Numis Securities Limited                          Tel: 020 7260 1000 
 Oliver Cardigan/ Paul 
  Gillam / 
 James Black 
 
 Walbrook PR Ltd            Tel: 020 7933 8780 / ilika@walbrookpr.com 
 Paul Cornelius                                    Mob: 07866 384 707 
 Lianne Cawthorne                                  Mob: 07584 391 303 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCJJMFTMBMBBFR

(END) Dow Jones Newswires

March 14, 2017 03:00 ET (07:00 GMT)

1 Year Ilika Chart

1 Year Ilika Chart

1 Month Ilika Chart

1 Month Ilika Chart

Your Recent History

Delayed Upgrade Clock